The continued success of abelacimab throughout the AZALEA-TIMI 71 trials helps draw the drug closer to FDA approval, stated ...

Boston Scientific has proven itself to be a fierce competitor among three major cardiac device makers, with a track record of meaningful innovation and impressive operational chops. Even a prolonged ...

Thanks to healthcare reform, the hurdles to securing reimbursement and technology add-on payments have risen. Boston will need to invest more in clinical studies to demonstrate superiority of outcomes ...

Researchers have developed an AI tool that creates synthetic yet medically accurate models of fibrotic heart tissue (heart scarring), aiding treatment planning for atrial fibrillation (AF) patients.

Currently assessed through specialised MRI scans (LGE-MRI), the pattern and distribution of this scarring significantly influences treatment outcomes. Atrial fibrillation is frequently treated with ...

In patients with AF, abelacimab, compared with rivaroxaban, is associated with decreased bleeding across multiple bleeding risk categories. Abelacimab is associated with reduced bleeding compared ...

Objective Atrial fibrillation (AF) has emerged as a common condition in older adults. Cardiovascular risk factors only explain about 50% of AF cases. Inflammatory biomarkers may help close this gap as ...

My watch has an electrocardiogram (EKG) function, and it immediately said I was in atrial fibrillation at a rate of 100-130 bpm. I went to the emergency room where they confirmed AFib, did a bunch ...

“We were glad to see the administration taking action. But the pattern of behavior since then has raised concerns that would be easy to address by being transparent about the charges, by creating a ...

The unveiling, on Wednesday, gave a first-ever glimpse at the company’s locally manufactured microemulsion flow battery (MeFB) technology, following the news earlier this week that Allegro ...

the researchers found that being diagnosed with atrial fibrillation before 70 years old was linked to a 21% higher risk of dementia, and a 36% higher chance of early-onset dementia. “Haemodynamic ...

New research presented at the EHRA 2025, a scientific congress of the European Society of Cardiology, shows that the presence of atrial fibrillation ... alterations in the flow and pressure ...